摘要
头颈部鳞状细胞癌(HNSCC)是世界上排名第六的最常见的癌症,在过去几十年间,其生存率并没有得到改善。目前的治疗手段包括手术、放射治疗和化疗,但是这些治疗手段对于复发或转移性肿瘤来说都是相对无效的。因此,寻找一种专门针对顽固HNSCC肿瘤干细胞(CSCs)的新型治疗手段迫在眉睫,CSCs是引起肿瘤初发和转移的族群。鉴于其对基因表达和生物进程的巨大影响,包括干细胞功能,非编码RNAs已经成为一种有前景的作为潜在的诊断和治疗靶点的基因研究的新课题。这篇综述对当前的调查研究进行了一个综合的概述,其将有助于我们了解在ncRNA和HNSCC肿瘤干细胞的生物学间的仍然停留在试验阶段的联系。我们这样做的目的是分析干细胞在HNSCC分子靶向癌症治疗的发展过程中的潜在的与干细胞相关的ncRNAs的作用。尽管大多数关于HNSCC和ncRNAD的现代化的知识主要集中于微小核糖核酸,我们仍然选择给予ncRNAs的其他种类(lncRNA、piRNA和 snoRNA)相当的关注,这些其他种类中的许多尚未被很好的了解或还没有被发现,从而代表了在HNSCC治疗中分子靶点或者生物标记的一个潜在的令人兴奋的而尚未被开发的宝库。
关键词: 肿瘤干细胞,头颈部鳞状细胞癌(HNSCC)
图形摘要
Current Drug Targets
Title:Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells
Volume: 15 Issue: 13
Author(s): Elham Rahimy, Selena Z. Kuo and Weg M. Ongkeko
Affiliation:
关键词: 肿瘤干细胞,头颈部鳞状细胞癌(HNSCC)
摘要: Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world and has not seen improved survival rates over the past few decades. Current treatment plans include surgery, radiation therapy, and chemotherapy, but these are relatively ineffective options for recurrent or metastatic tumors. Therefore, there is a high priority for new therapies that specifically target the resistant HNSCC cancer stem cells (CSCs), a subpopulation responsible for tumor initiation and metastasis. Given their vast effects on gene expression and biological processes, including stem cell capabilities, non-coding RNAs (ncRNAs) have become a promising new repertoire of genes to investigate as potential diagnostic or therapeutic targets. This review presents a comprehensive overview of current investigative studies that can contribute to our understanding of the still tentative link between ncRNA and the biology of HNSCC cancer stem cells. In doing so, we aim to analyze the potential role of stem cell-related ncRNAs in the development of molecularly targeted cancer therapy for HNSCC. Although the majority of updated knowledge on HNSCC and ncRNA focuses heavily on microRNA, we chose to give considerable attention to the promise of other classes of ncRNAs (lncRNA, piRNA, and snoRNA), many of which are not yet well characterized or are yet to be discovered, and thus represent a potentially exciting and untapped pool of molecular targets or biomarkers in HNSCC therapy.
Export Options
About this article
Cite this article as:
Elham Rahimy, Selena Z. Kuo and Ongkeko M. Weg, Evaluation of Non-Coding RNAs as Potential Targets in Head and Neck Squamous Cell Carcinoma Cancer Stem Cells, Current Drug Targets 2014; 15 (13) . https://dx.doi.org/10.2174/1389450115666141024113446
DOI https://dx.doi.org/10.2174/1389450115666141024113446 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
microRNA, Cancer and Cancer Chemoprevention
Current Molecular Pharmacology Selectively Targeted Anti-Neoplastic Cytotoxicity of Three Immunopharmaceuticals with Covalently Bound Fludarabine, Gemcitabine and Dexamethasone Moieties Synthesized Utilizing Organic Chemistry Reactions in a Multi-Stage Regimen
Current Pharmaceutical Design E-Cadherin Upregulation as a Therapeutic Goal in Cancer Treatment
Mini-Reviews in Medicinal Chemistry Natural Products Derived from Traditional Chinese Medicine as Novel Inhibitors of the Epidermal Growth Factor Receptor
Combinatorial Chemistry & High Throughput Screening Synthesis and Cytotoxicities of 2-[4-hydroxy-(3,5-bis-aminomethyl)- benzylidene]-indan-1-ones
Letters in Drug Design & Discovery Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Detection of Lung Cancer on Computed Tomography Using Artificial Intelligence Applications Developed by Deep Learning Methods and the Contribution of Deep Learning to the Classification of Lung Carcinoma
Current Medical Imaging The Epidermis as a Model for Tissue Engineering
Current Tissue Engineering (Discontinued) New Target Therapies for Brain Metastases from Breast Cancer
Current Cancer Drug Targets Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
Current Medicinal Chemistry Emerging Drug Target In Pancreatic Cancer: Placing Sirtuin 1 on the Canvas
Current Cancer Drug Targets From Natural Products to Designer Drugs: Development and Molecular Mechanisms Action of Novel Anti-Microtubule Breast Cancer Therapeutics
Current Topics in Medicinal Chemistry Current Status and Future of Target-Based Therapeutics
Current Cancer Drug Targets IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews Biological Effects of Curcumin and Its Role in Cancer Chemoprevention and Therapy
Anti-Cancer Agents in Medicinal Chemistry Molecular Biomarkers for Lung Adenocarcinoma: A Short Review
Current Cancer Therapy Reviews Epidemiology, Clinical Presentation and Treatment of Mucosal Melanoma
Clinical Cancer Drugs Toxic Epidermal Necrolysis and Antifolate Drugs in Cancer Chemotherapy
Current Drug Safety Impact of Epigenetic Dietary Components on Cancer through Histone Modifications
Current Medicinal Chemistry DNA Damage-inducing Compounds: Unraveling their Pleiotropic Effects Using High Throughput Sequencing
Current Medicinal Chemistry